NICE gives final nod to AZ's Brilique, Takeda's Mepact; Teva, Dr Reddy's launches Zyprexa copies;

 @FiercePharma: Mylan CEO to step down, leaving his spot open for President Heather Bresch; COO will step up to President - Reuters. Story | Follow @FiercePharma

> The National Institute for Health and Clinical Excellence gave a final OK to AstraZeneca's ($AZN) new blood thinner Brilique in combination with aspirin as a treatment for adults with acute coronary syndrome. News

> Takeda Pharmaceutical's new patient-access scheme persuaded NICE to accept Mepact as a treatment for bone cancer in children. Article

> Dr Reddy's Laboratories and Teva Pharmaceutical Industries ($TEVA) said they had launched generic versions of Eli Lilly's newly off-patent antipsychotic drug Zyprexa. Report

> Medco Health Solutions saw its generic-dispensation rate rise to a record 73.8%, 2.2 percentage points higher year-over-year. News

> Moody's Investors Service cut its outlook on Amgen's ($AMGN) credit ratings to negative, saying that the Big Biotech company's stock buyback program could lead to declining credit quality. Story

> German drug distributor Celesio, which has slashed its 2011 earnings outlook, is embarking on a major restructuring to cut costs and expand outside of Europe into faster-growing markets. Item

Biotech News

 @FierceBiotech: Special Report: Top 15 blockbuster contenders in the biopharma pipeline. Report | Follow @FierceBiotech

 @JohnCFierce: Last Feb. Conatus raised $20M from VCs, including Roche, largely on the promise of 1027.| Follow@JohnCFierce

 @MaureenFierce: Leto Medical's logo makes me want a pina colada. RT @FierceMedDev: 5 interesting medtech logos. Report | Follow @MaureenFierce

> Sir Chris and the Finns take opposite views on Merlin's real value. Item

> Biotech founder counters the skeptics with anti-aging program. Report

Drug Delivery

> MonoSol targets drug film rival's revenue in updated court complaint. Item

> Shire pump bypasses hurdle to sneak enzyme drug into brain. Story

> DLVR Therapeutics grabs $2M in seed support, advancing nanoparticle delivery. Article

Medical Device News

> Quest begins search for CEO. Article

> FDA raises concerns about Medtronic heart device. News

> Foundation Medicine to collaborate with J&J unit. Story

And Finally... Eight drugmakers have agreed with the United Nations to pool patented information and proprietary data to spark research into neglected tropical diseases. Article

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.